Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...

Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...

40. The Waterboys – The Life and Death of Dennis Hopper (Sun Records) ...

Get the latest Dragonfly Energy Holdings Corp. (DFLI) stock news and headlines to help you in your trading and investing decisions.

BLDP Ballard Power Systems Inc.